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Embryonic megakaryopoiesis starts in the yolk sac on gestational day7.5 as part of the primitive wave of hematopoiesis, and it continues inthe fetal liver when this organ is colonized by hematopoietic progeni-
tors between day 9.5 and 10.5, as the definitive hematopoiesis wave. We
characterized the precise phenotype of embryo megakaryocytes in the liver
at gestational day 11.5, identifying them as CD41++CD45-
CD9++CD61+MPL+CD42c+ tetraploid cells that express megakaryocyte-spe-
cific transcripts  and display differential traits when compared to those pres-
ent in the yolk sac at the same age. In contrast to megakaryocytes from adult
bone marrow, embryo megakaryocytes are CD45- until day 13.5 of gesta-
tion, as are both the megakaryocyte progenitors and megakaryocyte/ery-
throid-committed progenitors. At gestational day 11.5, liver and yolk sac
also contain CD41+CD45+ and CD41+CD45- cells. These populations, and
that of CD41++CD45-CD42c+ cells, isolated from liver, differentiate in culture
into CD41++CD45-CD42c+ proplatelet-bearing megakaryocytes. Also present
at this time are CD41-CD45++CD11b+ cells, which produce low numbers of
CD41++CD45-CD42c+ megakaryocytes in vitro, as do fetal liver cells express-
ing the macrophage-specific Csf receptor-1 (Csf1r/CD115) from MaFIA
transgenic mice, which give rise poorly to CD41++CD45-CD42c+ embryo
megakaryocytes both in vivo and in vitro. In contrast, around 30% of adult
megakaryocytes (CD41++CD45++CD9++CD42c+) from C57BL/6 and MaFIA
mice express CD115. We propose that differential pathways operating in the
mouse embryo liver at gestational day 11.5 beget CD41++CD45-CD42c+
embryo megakaryocytes that can be produced from CD41+CD45- or from
CD41+CD45+ cells, at difference from those from bone marrow.
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ABSTRACT
Introduction
Megakaryocytes are the hematopoietic cells responsible for the production of
platelets. In adults, these cells are generated in the bone marrow (BM) from
hematopoietic stem cells (HSC) via a common megakaryocyte and erythroid progen-
itor (MEP) that expresses the receptor for SCF (c-Kit) and is negative for lineage-spe-
cific antigens (Lin-), for the stem cell antigen-1 (Sca1), and for the fms-related tyrosine
kinase 3 receptor, Flt3/CD135 (Flt3-LS-K cells).1 Nevertheless differentiation into all
hematopoietic lineages, including the megakaryocyte/erythroid, from Flt3+ progeni-
tors was also obtained.2 The hierarchical model of hematopoiesis defines progres-
sively restricted lineage-committed progenitors. From HSC a pool of multipotent pro-
genitors (MPP) produces common lymphoid progenitors (CLP) and common myeloid
progenitors (CMP), these latter giving rise to MEP and granulocyte/macrophage pro-
genitors (GMP).3,4 However, several recent reports suggest that megakaryocyte/ery-
throid-commitment may happen directly from HSC or from MPP, supporting a
model of multiple lineage commitments occurring in parallel within the HSC/MPP
cell pool.5-8 Among CMP, CD41+ cells that express a megakaryocyte-specific signa-
ture, platelet factor 4 (PF4), CD9, von Willebrand factor
(VWF), are separated from erythroid progenitors, and closer
to other myeloid progenitors expressing Flt3 and the
macrophage colony-stimulating factor-1 receptor
(Csf1r/CD115).7 Clonal unilineage megakaryocyte progeni-
tors (MKP) were defined as burst-forming unit megakary-
ocytes (BFU-MK) and as colony-forming unit megakary-
ocytes (MK-CFU), and were Lin-c-Kit+Sca1-
FcγRII/IIIloCD127-Thy1.1-CD9++CD41+ cells expressing the
thrombopoietin receptor (myeloproliferative leukemia
virus, MPL).1,9 Other studies revealed distinct lineage poten-
tials among erythromyeloid progenitors,10 defining
megakaryocyte/erythroid-committed progenitors
(PreMegE) as Lin-Sca1-c-Kit+FcγR-CD105-CD150+CD41- and
MKP, exclusively associated with megakaryocyte genera-
tion, as Lin-Sca1-c-Kit++CD150+CD41+.
Embryo hematopoiesis proceeds in two phases, primitive
and definitive, which are conserved among different
species, including mice and humans.11,12 In the mouse, a
primitive wave of erythromyeloid cells forms in the yolk
sac (YS) at E7.5.13,14 At E8.5 erythromyeloid progenitors are
generated in the YS and the intraembryonic paraaortic
splanchnopleura/aorta-gonads-mesonephros region (P-
Sp/AGM), the latter also containing progenitors with lym-
phoid activity.15-17 Definitive HSC that are the source of all
adult hematopoietic cell lineages are present in the P-
Sp/AGM at E10.5.18 The emergence of these definitive HSC
in the embryo is dependent on the expression of the tran-
scription factor RUNX1,19 which is required for progression
of CD41+ embryonic precursors into HSC.20 The fetal liver
(FL) represents the major hematopoietic organ during gesta-
tion, receiving extrinsic HSC and MPP from the YS, P-
Sp/AGM and the placenta at E10.5. MEP involved in prim-
itive and definitive megakaryopoiesis appear in the YS at
E7.25 and at E9.5, respectively.21,22 RUNX1-independent
diploid platelet-forming cells have been identified in the YS
at E8.5/10.5.23 Moreover, CD42c+ megakaryocytes can be
identified in the YS, in circulation and in the FL from E9.5
onwards, and large reticulated immature platelets circulate
at E10.5.21,24
Embryo-derived megakaryocytes differ from those from
the adult BM, as illustrated by the in vitro effects of throm-
bopoietin,25 cell-intrinsic differences in vivo after transplanta-
tion26 and the smaller size of those from YS.22 In the FL from
E10.5-E11.5 mice, megakaryocytes progressively increase in
size and ploidy.27 However, despite several reports on BM-
derived megakaryopoiesis published recently, the interme-
diate cells that appear during this process early in life, and
the changes in surface phenotype, have yet to be fully
defined. 
We found previously that at E10.5/E11.5, FL megakaryo -
cytes are c-KitDCD49f++CD41++CD9++CD42c+VWF+ and
they rapidly produce, independently of thrombopoietin
stimulation, proplatelet-bearing megakaryocytes (P-MK) in
vitro.28 Strikingly, these FL megakaryocytes were
CD41++CD45-, as were the diploid platelet-forming cells
found in the YS.23 Here we show that, unlike those from
BM, FL megakaryocytes remain CD45- until E13.5, as do
the PreMegE and MKP. However, both CD41+CD45+ and
CD41+CD45- cells are present in the FL, these populations
bearing MK-CFU, megakaryocyte gene expression, and
containing Lin-Sca1-c-Kit++CD150+CD41+ MKP. These cells
develop into CD41++CD45-CD42c++ P-MK in vitro. The E11.5
FL also contains CD41-CD45++CD11b+ cells that produce
CD41+CD45+ cells in vitro, although they do not develop
into P-MK. Accordingly, CD45++EGFP+ cells from E11.5 FL
ex vivo preparations from MaFIA transgenic mice, which
trace cells expressing Csf1r/CD115,29 give origin poorly to
CD41++ cells both in vivo and in vitro. Interestingly, a high
proportion of adult BM CD41++CD45++CD9++CD42c++
megakaryocytes from C57BL/6 mice express CD115 and
are EGFP+ in MaFIA mice. Our results identify different
pathways of megakaryopoiesis in the mouse embryo FL
and in adult BM, driven by distinct MKP expressing or not
CD45. 
Methods
Mice and embryo microsurgery and cell suspensions
BALB/c, C57BL/6 and C57BL/6-Tg(Csf1r-EGFP-
NGFR/FKBP1A/TNFRSF6) 2Bck/J MaFIA29 mice were maintained
at the animal facilities of the Instituto de Salud Carlos III. All animal
studies were approved by the Animal Health Ethics Authority
from the Autonomous Government of Madrid (PROEX 080/15).
Embryo microsurgery and cell suspensions were obtained as
described previously28 and in the Online Supplementary Methods.
Flow cytometry and cell purification 
Cells were stained as reported elsewhere,28 with the fluo-
rochrome-labeled antibodies described in the Online Supplementary
Methods and Online Supplementary Tables S1 and S2. 
Quantitative real-time polymerase chain reaction
analysis
RNA was extracted, oligo(dT)-primed cDNA samples were pre-
pared and quantitative real-time polymerase chain reaction (RT-
qPCR) amplifications were performed with the primers and pro-
tocols described,30,31 as indicated in the Online Supplementary
Methods and Online Supplementary Table S3.
Colony-forming cell assays and cell cultures
Clonal semisolid cultures and cultures of purified cell popula-
tions were performed as indicated in the Online Supplementary
Methods. 
Immunofluorescence
Immunostaining was performed on cryosections from YS and
embryos as indicated in the Online Supplementary Methods. The
preparations were analyzed by confocal microscopy (Leica
DMRD) and the images were processed with ImageJ software. 
Statistical analysis
GraphPad Prism 4.0 software was used to calculate the means
and standard error of the mean (SEM). Comparisons were per-
formed with unpaired and paired Student t tests, with the χ2 test
or the Kruskal-Wallis test, to obtain the P values. Data are
expressed as mean ± SEM. A P-value less than 0.05 was defined as
statistically significant; statistical significance is shown as *P<0.05,
**P<0.01 and ***P<0.001. 
Results
Megakaryocyte lineage cells are present in hematopoi-
etic organs and blood vessels during post-gastrulation
embryo development
Co-expression of the CD41/aIIa integrin (GPIIb) and
CD42c/GPIb-β chains was used to trace megakaryocytes
and platelets by flow cytometry. CD41++CD42c+
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megakaryocytes were detected from E9.5 in the YS, and in
the circulating peripheral blood mononuclear cells and the
P-Sp/AGM from this moment on (Figure 1A). Similarly,
CD41++CD42c+ cells were found from E10.5 in the FL,
although the mean fluorescence intensity (MFI) of CD41
in CD41++CD42c+ megakaryocytes was weaker than that
at other locations, as particularly evident in E11.5 samples
(Figure 1B). CD41++CD42c+ megakaryocytes were more
abundant in the YS than in the P-Sp/AGM and FL at E10.5,
and their numbers increased along gestation (Figure 1C).
Cells in the window corresponding to platelets (low for-
ward scatter/side scatter on a log scale) were also detected
in the YS and FL from E8.5 and E10.5, respectively, and
they were in the circulation from E9.5 (Figure 1D) as
described previously.23 Consistent with previous reports,21
the earliest platelets were large and although their size
diminished in the YS and FL as gestation progressed, those
circulating remain large until E13.5 (Figure 1E). 
Megakaryocytes in the E9.5-E11.5 mouse embryo
accumulate in the fetal liver 
To trace the anatomic distribution of CD41++
megakaryo cytes at E11.5 in the YS and embryo, immuno-
fluorescence analyses were performed. YS preparations
contained clusters of small CD41++ cells that may corre-
spond to aggregated platelets, as well as individual
megakaryo cytes (Figure 2A). In the embryo proper,
CD41++ megakaryocytes were enriched in the FL. From
E10.5 to E15.5, FL CD41++ megakaryocytes increased in
volume and enhanced the complexity of the so-called
membrane demarcation system (DMS, involved in pro-
platelet formation), indicating maturation to megakaryo -
CD45-negative megakaryopoiesis in the mouse embryo
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Figure 1. Megakaryocyte lineage cells are present from E9.5 in the mouse embryo. Cell suspensions from hematopoietic locations in the embryo were prepared
and stained with anti-CD41-PE and anti-CD42c-FITC for cytometry. (A) Representative dot-plots of the staining of cell suspensions from the yolk sac (YS), paraaortic
splanchnopleura/aorta-gonads-mesonephros region (P-Sp/AGM), peripheral blood mononuclear cells (PBMC) and fetal liver (FL) at the gestational ages indicated
(from E8.5 to E11.5). The quadrants define positive cells (determined by using fluorescence-minus-one control isotypes) and the numbers inside the plots are the
frequencies of CD41++CD42c+ cells [mean ± standard error of mean (SEM) n=5, n=6, n=7, and n=16 for E8.5, E9.5, E10.5 and E11.5, respectively]. (B) The bar
graphs show the mean fluorescence intensity (MFI) of the CD41 fluorescence among CD41++CD42c+ cells from the locations indicated at E11.5. (C) Absolute numbers
of CD41++CD42c+ cells in the YS, P-Sp/AGM and FL from E8.5-E13.5, as derived from the frequencies displayed in the histograms in panel (A) and the total number
of cells recovered per organ in each preparation. (D) Representative dot-plots of the CD41 and CD42c staining in cells gated in the low side scatter (SSC)/forward
scatter (FSC) window shown in the left dot-plot with the scale FSC as logarithmic, corresponding to platelets. (E) The graph represents the size (determined by the
mean FSC channel) of the cells identified in the low SSC/FSC platelet window, in the YS, PBMC and FL from E8.5 to E13.5. The data in the graphs in (B, C and E)
are the means ± SEM [numbers as in panel (A), and n=8 and 17 for E12.5 and E13.5, respectively]. Fluorescence scales are logarithmic. The group comparisons
were performed with a two-tailed Student t-test. **P<0.01 and ***P<0.001.
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cyte stages with increased ploidy32 (Figure 2B-E). In fact,
most CD41++CD42c+ megakaryocytes from E11.5 FL were
tetraploid (4N or more) (Figure 2F). By contrast, YS CD41++
megakaryocytes were smaller and mostly diploid, as
described for the diploid platelet-forming cells.23 At E10.5,
FL megakaryocytes displayed a less complex membrane
demarcation system than the concurrent YS diploid
platelet-forming cells, although the latter did not reach
greater membrane demarcation system complexity at
E11.5, as did those from FL (Figure 2D).
As we found previously,28 E11.5 CD41++VWF+
megakaryocytes were consistently CD45-, and only weak
CD45 signals were detected in CD41lo cells (Figure 3A).
Flow cytometry analyses of YS and FL cell suspensions
from E10.5-E15.5 embryos showed that CD41++CD42c+
megakaryocytes were mainly CD45- in the YS and FL until
E13.5 (population #1 in Figure 3B-C), whereas CD45+ cells
were detected among the CD41+CD42c- cells (population
#2) in these same preparations. Also, most embryo
megakaryocytes from E11.5 placenta were CD45- (Figure
3C). From E13.5 onwards, CD41++CD42c+ megakaryo -
cytes displayed low levels of CD45, which increased at
E15.5, and megakaryocytes from adult BM were CD45+
(Figure 3C). Accordingly, CD45 was not detected by RT-
qPCR in CD41++CD42c+ samples from the YS and FL at
E11.5, while they expressed Runx1 (Figure 3D). 
The fact that CD41++CD42c+ megakaryocytes were
mostly CD45- in the YS and FL until E13.5 suggested that
the initial FL megakaryocytes may be derived by the hom-
ing of CD45- megakaryocytes from the YS. The expres-
sion of selected markers by the CD41++CD45- cells present
in the YS and FL between E10.5 to E11.5 (c-Kit and
CD42c) (Table 1) indicated a maturation of these cells in
the YS (the brightness of c-Kit dropped and the expression
of CD42c increased) that was not so evident in the FL dur-
ing the same period, and consequently at E11.5
CD41++CD45- cells in the FL showed weaker CD41 fluo-
rescence (Figure 1B), and  stronger c-Kit expression (Table
1) than those in the YS at E11.5. 
Therefore, our data show that at E11.5 YS and FL
megakaryocytes differ in their cell volume and ploidy.
Those from YS are diploid platelet-forming cells while
I. Cortegano et al.
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Figure 2. Topographical and morphological characteristics of embryo megakaryocytes. Immunofluorescence analyses on E11.5 yolk sac (YS) and embryo tissue
slices (10 μm) stained with anti-CD41-FITC (green), and counterstained with DAPI. Representative photomicrographs are shown. The scale bar indicates the magni-
fication of the photomicrographs. (A) The upper photomicrographs show two views of YS samples. The white boxes define the areas magnified in the bottom pho-
tomicrographs. (B) The photomicrographs show fetal liver (FL) samples at the gestational ages indicated. (C) Higher magnification of representative megakaryocytes
displaying the increased complexity of the membrane demarcation system (DMS) used to define the Pre-DMS (i), Inter-DMS (ii and iii) and Late-DMS (iv) stages. (D)
The bar graph displays the relative number (percentage) of YS and FL megakaryocytes presenting the DMS stages identified in the CD41++ megakaryocytes at the
gestational ages indicated. (E) The graph displays the cell volume of CD41++ cells. The volume (πD3x1.33) was calculated after measuring the cell diameter “D”. One
hundred cells were counted in 20 different photomicrographs for each time point. Data in panels (D) and (E) are the mean ± standard error of mean (SEM) for YS
preparations at E9.5 (n=6), E10.5 (n=9) and E11.5 (n=9), and for FL samples at E10.5 (n=3), E11.5 (n=16), E13.5 (n=9) and E15.5 (n=8). (F) Left, representative
histograms showing the DAPI staining in nuclei of electronically gated CD41++CD42c+ embryo-derived megakaryocytes (EMK) present in cell suspensions from YS and
FL at E11.5; right, quantification of cells with 2N, 4N or >4N ploidy among CD41++CD42c+ EMK. The mean ± SEM are shown (n=3). Comparisons were performed in
contingency tables with χ2 and Fisher exact tests. **P<0.01 and ***P<0.001.
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those in FL are bigger and mostly tetraploid cells, and
express higher levels of Runx1, even though they bear less
CD41 and CD42c intensity than those in the YS. From
E11.5 to E15.5, FL megakaryocytes increase in size, as well
as membrane complexity and become CD45+. 
Weak CD45 expression in megakaryocyte progenitors
in the E11.5 embryo
In the adult BM, all nucleated stages of megakaryocyte
differentiation are CD45+.33 Since most megakaryocytes
were CD45- at E11.5, we wondered whether megakaryo -
cyte lineage-committed progenitors were also CD45- at
these embryonic stages. We therefore determined the
number of cells expressing CD45, and the levels of CD45,
among LSK, PreMegE, MKP, CMP, GMP and CLP cells
(their phenotypes are defined in Online Supplementary
Table S1) in E11.5 FL cell suspensions, comparing these
with cells from the liver and BM of newborn mice (post-
natal day 3, PD3) and from those in the adult BM. The
level of CD45 expression was weaker in E11.5 samples
than in those from adult mice. Remarkably, both the fre-
quency of cells expressing CD45 and the levels of CD45
CD45-negative megakaryopoiesis in the mouse embryo
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Figure 3. Megakaryocytes and megakaryocyte-lineage committed progenitors are CD45- in the yolk sac and embryo at E10.5-E13.5. (A) Left photomicrograph: the
fetal liver (FL) in an embryo preparation stained with anti-CD41 (green) and anti-CD45 (red). The boundaries of the vessel (V) are indicated by the dotted line. Right
photomicrographs: higher magnification of cells indicated by the white boxes showing overlaid signals and separated in channels. Green CD41++ cells negative for
the red CD45 stain are shown. (B) Yolk sac (YS) and FL cell suspensions from E10.5, E11.5, E13.5 and E15.5 embryos were stained with anti-CD41-PE, anti-CD42c-
FITC and anti-CD45-PE-Cy7. The upper-left dot-plot displays a representative CD41/CD42c staining showing the CD41++CD42c+ megakaryocytes and CD41+CD42c-
cell populations (labeled as 1 and 2, respectively) analyzed for expression of CD45 in the histograms. The vertical lines in the histograms indicate the fluorescence-
minus-one (FMO) isotype control limit. Numbers inside the histograms are the percentages of positive cells. (C) Bar graphs showing the quantification (relative num-
ber) of CD45+ cells among the CD41+CD42c- cells and CD41++CD42c+ megakaryocytes. The mean ± standard error of mean (SEM) for E10.5 (n=9), E11.5 (n=9),
E13.5 (n=9), E15.5 (n=8), placenta (n=4) and adult bone marrow (BM) (n=4) is shown. (D) CD45 and Runx1 expression analyzed by real-time quantitative poly-
merase chain reaction on samples of purified CD41+CD42c- and CD41++CD42c+ cells from the E11.5 YS and FL. The results were calculated relative to the expression
of the HPRT housekeeping gene using the 2-DCt method. The data are the mean ± SEM (n=4). Results for total FL at E11.5 are shown as C+. (E) After tracing and
electronically excluding Lin+ cells with biotin-labeled antibodies against Ter119, B220, CD19, CD11b and anti-CD90.2 revealed with the fluorochrome-labeled strep-
tavidin indicated below, progenitor populations in E11.5 FL and adult BM cell suspensions were identified by multicolor flow cytometry by using combinations of anti-
bodies, as follows: (i) anti-Sca1-PE-Cy7, anti-c-Kit-APC, anti-Flt3-PE, and streptavidin-FITC to identify LSK (Lin-c-Kit++Sca1+) cells and common lymphoid progenitors
(CLP: Lin-c-Kit+Sca1+); and (ii) anti-c-Kit-APC, anti-CD34-BV421, anti-FcγRII/III-FITC, anti-CD150-PerCp-Cy5.5, and anti-CD41-PE, with anti-Sca1-PE-Cy7 and strepta-
vidin-PE-Cy7, to identify granulocyte/macrophage progenitors (GMP: Lin-c-Kit++Sca1-CD34+FcγRII/III++), common myeloid progenitors (CMP: Lin-c-Kit++Sca1-
CD34++FcγRII/III-), megakaryocyte/erythroid-committed progenitors (PreMegE: Lin-Sca1-c-Kit+CD150++CD41-) and megakaryocyte progenitors (MKP: Lin-Sca1-c-
Kit+CD150++CD41+). CD45 expression was monitored with anti-CD45-APC-Cy7. The histograms show the expression of CD45 by progenitor cells in the E11.5 FL and
adult BM (filled gray histograms). The FMO isotype signal is shown overlaid (dotted line). The data shown are from one representative experiment. Fluorescence
scales are logarithmic. (F) The quantification (frequency) of CD45+ cells and their mean fluorescence intensity (MFI) in the CD45 channel are shown in the bar
graphs. The horizontal dotted line represents the isotype background limit. The data in the graphs are the means ± SEM (n=5), comparing the groups with the two-
tailed Student t-test. *P<0.05, **P<0.01 and ***P<0.001.
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were much lower in LSK cells, PreMegE and MKP at E11.5
than in adult BM (Figure 3E-F). In neonates, CD45 expres-
sion increased in progenitors from liver, although remain-
ing lower in PreMeg and MKP than in those from neonatal
and adult BM (Online Supplementary Figure S1). Hence, our
data show that at E11.5, not only megakaryocytes, but
also LSK, PreMegE and MKP display less CD45 than at
PD3 and in adult mice.
CD45+ and CD45- megakaryocyte lineages are present
at E11.5
Adult BM megakaryocytes are Lin-CD41++CD45+ acetyl-
cholinesterase (AChE)+, while immature megakaryocytes
are Lin-CD45+CD41+AChE-.34 To identify whether
CD41+CD45+ immature megakaryocytes equivalent to
those from BM were present in the E11.5 embryo, we ana-
lyzed CD41/CD45 expression in cell preparations from the
YS and FL. At E11.5 there are CD45+ cell populations that
are negative or positive for CD41 (R1/CD41-CD45++ and
R2/CD41+CD45+, respectively). Among CD45- cells there
are cells expressing low or high levels of CD41
(R3/CD41+CD45- and R4/CD41++CD45-, respectively), or
negative for it (DN cells). R2/CD41+CD45+ cells were high-
ly prominent in the YS at E9.5 and E10.5, and R1/CD41-
CD45++ and R3/CD41+CD45- cells, the first apparent from
E10.5, and increasing as development proceeded (Figure
4A-B). Signals for AChE were obtained only for the puri-
fied R2/CD41+CD45+ and R4/CD41++CD45- cell subsets
(Figure 4C). The R2/CD41+CD45+ cells in FL can be further
subdivided based on higher or lower CD45 level (Online
Supplementary Figure S2C; R2a and R2b, respectively), with
few CD45+ cells displaying high levels of CD41 (Online
Supplementary Figure S2C,D; R2c). Expression of the
megakaryocyte-related cell surface markers CD42c, MPL,
CD9 and CD61 was found in R4/CD41++CD45- and
R3/CD41+CD45- cells in YS and FL at E10.5/E11.5, and also
in the R2c/CD41++CD45+ cell subset in FL (Figure 4D and
Online Supplementary Figures S2 and S3). Since the number
of R2c/CD41++CD45+ cells was low (Online Supplementary
Figure S2D), there were fewer CD41++CD45+CD42c+
megakaryocytes than CD41++CD45-CD42c+ megakary-
ocytes at E10.5-E11.5, in agreement with the results dis-
played in Figure 3B,C. Megakaryocyte-lineage-specific
transcripts NF-E2, PF4, VWF and Fli1 were expressed by
R4/CD41++CD45- cells, which displayed myeloid-specific
transcripts (PU1 and myeloperoxidase)  very weakly
(Figure 4E, and data not shown). From now on we will refer
to the CD41++CD45-CD42c+ megakaryocytes present in
the R4 region in FL samples as embryo-derived megakary-
ocytes (EMK), and to the CD41++CD45+CD42c+ cells as
adult-type megakaryocytes (AMK). When analyzed for the
presence of earlier hematopoietic progenitors by flow
cytometry (Figure 4F), R4/CD41++CD45- cells comprise
only few MKP besides the EMK. Accordingly, when the
differentiation potential of purified R4/CD41++CD45- cells
from E11.5 FL cell suspensions was analyzed on clonal
MegaCult and MethoCult assays (Figure 4G), they only
produced megakaryocyte lineage colonies (MK-CFU), and
myeloid lineage colonies (M-CFU) in which P-MK were
detected as individual cells, like CD45+CD41++CD42c+
megakaryocytes from adult BM (Online Supplementary
Figure S4C). 
The R2/CD41+CD45+ and R3/CD41+CD45- cell subsets
also expressed VWF, yet they had a mixture of other pro-
genitors, containing Lin-c-Kit++ subpopulations with the
phenotype of GMP, MKP, low numbers of CMP, and in the
case of R3/CD41+CD45- cells, also PreMegE, as did
CD41+CD45+ cells from adult BM (Online Supplementary
Figure S4A,B). Consequently, R2/CD41+CD45+ cells from
FL and BM produced both MK-CFU and M-CFU, and the
R3/CD41+CD45- cell population from FL produced E/M-
CFU (Figure 4G and Online Supplementary Figure S4C). On
the other hand, R1/CD41-CD45++ cells were mainly
Lin+CD11b+, but also contained CLP, CMP and GMP, and
produced M-CFU and E/M-CFU. Likewise they accumu-
lated PU1 and myeloperoxidase myeloid-specific tran-
scripts, as did the R2/CD41+CD45+ cells (Figure 4E-G). By
contrast, purified DN/CD41-CD45- cells mostly produced
E-CFU progenitors and no MK-CFU (Figure 4G).
In summary, the expression of AChE and other surface
and molecular markers, as well as clonal megakaryocyte
and hematopoietic lineage differentiation assays indicated
that R4/CD41++CD45-CD42c+ cells are EMK with low pro-
liferative activity and prone to develop proplatelets in vitro,
as expected for mature megakaryocytes. The
R2/CD41+CD45+ and R3/CD41+CD45- cells contain oligo-
clonal progenitors including MKP, which could represent,
respectively, CD45+ adult-like intermediate stages (iAMK)
and CD45- embryo intermediate stages (iEMK) in the dif-
ferentiation of the megakaryocyte lineage. 
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Table 1. Expression of surface receptors in CD45-CD41++ megakaryocytes from the yolk sac and fetal liver.
                                          E10.5 YS            E11.5 YS             E10.5 FL              E11.5 FL                 P value                    P value                    P value
                                                                                                                                                     E11.5 YS/FL         YS E10.5/E11.5       FL E10.5/E11.5
MFI
               c-Kit-APC                    246±35                  188±10                   281±10                    273± 14                     P<0.001                         P<0.05
                                                         (3)                       (12)                         (3)                          (12)
               CD42c-FITC                402±11                  474±10                    326±9                     383±12                      P<0.001                        P<0.001                          P<0.01
                                                        (8)                       (10)                        (7)                          (8)
Frequency
               c-Kit-APC                     60±11                     63±2                       75±7                        77±4                         P<0.01
                                                        (4)                       (6)                       (5)                        (6)
               CD42c-FITC                  90±1                      95±1                       82±2                        90±1                         P<0.01                          P<0.01                           P<0.01
                                                       (8)                       (8)                        (8)                        (8)
The mean fluorescence intensity (MFI) of electronically gated CD45-CD41++ cells was determined. Values are the mean ± standard error of mean and (number). The statistical
significances were calculated using unpaired and paired t tests (the latter when values were obtained from the same pools of embryos). E: embryonic day; YS: yolk sac; FL:
fetal liver. 
In vitro megakaryocyte differentiation stages from
CD45+ and CD45- megakaryocyte lineages in the fetal
liver at E11.5
In order to reproduce the steps of megakaryocyte differ-
entiation in vitro, we used short-term liquid cultures
(STLC) to trace the differentiation of cells from purified
R1-R4 E11.5 FL cell suspensions defined in Figure 4A, and
from purified adult BM CD41+CD45+CD42c- and
CD41++CD45+CD42c+ cells. These STLC have the advan-
tage of rapidly producing sufficient cells for phenotypic
and genetic analyses while allowing morphological
changes to be observed. After 24 h in STLC, EMK (R4)
from E11.5 FL produced adherent cells and other elongat-
ed and mobile cells which, after 48 h, emitted proplatelets
and were CD41++CD45-CD42c++ P-MK (Figures 5A-D).
STLC of R2/CD41+CD45+ cells also contained
CD41++CD42c+ megakaryocytes that were either CD45+
or CD45-, and very few CD41+CD45+ cells (3.6% ± 1.5%,
n=4). Similar results were obtained in STLC with
R3/CD41+CD45- progenitors, although the CD41++CD42c+
cells that developed there were mostly CD45- (Figure 5B).
DNA content analysis of the CD41++CD42c++ megakaryo -
cytes growing in the STLC from FL R2-R4 cell subsets
showed that they accumulated in the 8N stage although
the megakaryocytes generated in R4/CD41++CD45- cell
STLC reached higher ploidy (Figure 5C). 
Consistent with the myelo/monocyte traits expressed
by R1/CD41-CD45++ cells, these cells generated CD41-
CD45++CD11b++ cells in STLC, and also CD41++CD45+/-
CD42c+CD11b- cells (Figure 5B and Online Supplementary
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Figure 4. CD45+ and CD45- megakaryocyte subsets are present at E11.5 in the yolk sac and fetal liver. Flow cytometry studies were performed on preparations
from E11.5 fetal liver (FL) cell suspensions using Ter119-PerCP.Cy5.5, CD41-PE, CD45-PE-Cy7 and CD42c-FITC antibodies to analyze CD41/CD45/CD42c expression
after electronically excluding Ter119+ cells. Fluorescence scales are logarithmic. (A) Representative contour plots of the yolk sac (YS) and FL cell preparations at the
indicated gestational ages. The boxes inside the dot plots identify four cell subsets expressing CD45 and/or CD41, which are labeled (R1-R4 and DN) as indicated
in the YS E11.5 dot-plot. (B) The bar graphs represent the frequency of each population (R1-R4) as the means ± standard error of mean (SEM) (E9.5, n=6; E10.5,
n=8; E11.5, n=9). (C) Acetylcholinesterase (AChE) expression (brown dots) was determined in the purified cell populations indicated from the E11.5 FL.
Representative photomicrographs from one of three experiments of hematoxylin-eosin counterstained cells are shown. C+ cells are purified CD9++CD41++CD42c+ cells
from E17.5 FL cell suspensions. Bar, 10 μm. (D) Representative histograms showing the expression of CD42c (gray histograms) in the populations defined in (A), in
which each point was analyzed at least three times. The fluorescence-minus-one (FMO) isotype signal is shown overlaid (dotted line). The numbers inside the plots
represent the frequency of CD42c+ cells in this experiment, representative of three performed with similar results. (E) Expression of NF-E2, VWF, PF4, PU1 and MPO
transcripts in cDNA samples from the E11.5 FL CD45/CD41 cell populations purified by flow cytometry as indicated in panel (A). The values for each transcript were
calculated relative to the HPRT gene using the 2-DCt method. The bars represent the means ± SEM. R1, n=5; R2, n=4; R3, n=9; R4, n=6. (F) Relative numbers of pro-
genitor cells present in the indicated CD45/CD41 cell subsets. The data are means ± SEM. (n=3). Progenitor cell populations were identified as in Figure 3E-F and
Online Supplementary Table S1. (G) Clonal differentiation assays. Purified cells from the E11.5 FL populations indicated were seeded in semisolid MegaCult medium
(upper graph) and in semisolid MethoCult medium (bottom graph). The colonies grown in MethoCult (erythroid and myeloid colony-forming units: E-CFU and M-CFU)
and MegaCult (megakaryocyte colony-forming units: MK-CFU) were counted at 3, 7 and 10 days, respectively. The data are the means ± SEM (n=4). Comparisons
among groups were performed with the two-tailed Student t-test. *P<0.05, **P<0.01 and ***P<0.001.
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Figure S5A). Accordingly, after STLC there was a bias
towards myeloperoxidase expression in cultures from
R1/CD41-CD45++ cells and towards PF4 in those from
R2/CD41+CD45+ cells, R3/CD41+CD45- cells and
R4/CD41++CD45- EMK (Figure 5E). The
CD41++CD45+CD42c+ megakaryocytes generated in
R1/CD41-CD45++ STLC were not elongated nor did they
present a P-MK morphology (Figure 5D). Therefore, dur-
ing the differentiation to CD41++CD45- megakaryocytes
from CD41-CD45++ and CD41+CD45+ cells, a reduction of
CD45 levels occurred in conjunction with an increase of
CD42c (Figure 5F). Although we found a reduction in the
CD45 transcript levels from CD41+CD45+ cells in STLC
(Online Supplementary Figure S5B), to rule out that the
decrease in expression of membrane-bound CD45 was
due to the use of anti-CD45 for the isolation of the cells,
we performed STLC with isolated CD31++CD42c- cells
that contained most CD45+/++ cells.28 After 48 h, the
CD31++CD42c- cells gave rise to CD42c+ cells that had
reduced their CD45 levels (Online Supplementary Figure
S5C). By contrast, STLC from CD41+CD45+CD42c- and
CD41++CD45+CD42c+ BM-purified cells (Online
Supplementary Figure S4D-E) allowed the growth of large
cells and P-MK displaying large proplatelets after 96 h,
reaching ploidy stages up to 64N. The megakaryocytes
(CD41++CD42c+) in these cultures were consistently
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Figure 5. The CD41+CD45- and CD41+CD45+ cell populations from E11.5 fetal liver produce megakaryocytes in vitro. Cells from the CD41/CD45 populations indi-
cated in Figure 4A were isolated by flow cytometry from E11.5 fetal liver (FL) cell suspensions, and cultured in short-term liquid cultures (STLC) in the presence of
50 ng/mL recombinant murine thrombopoietin, either in 96-well plates or 8-well culture slides. After 24 and 48 h the cultures were photographed under light
microscopy and the cells were counted in function of their morphology. After 48 h the cells were recovered and stained in suspension with anti-CD41-PE, anti-CD45-
PE-Cy7 and anti-CD42c-FITC antibodies for cytometry analyses, or stained in the slides with anti-CD41-biotin/Tyr.Cy3 and anti-CD42c-FITC antibodies. (A)
Representative contour plots of cells after the sorting procedure for each population are shown in the upper plots. Below-left, a representative photomicrograph (left
panel) of R2/CD41+CD45+ cells growing in STLC showing an adherent cell (asterisk, ADH); elongated, mobile cell (arrowhead, EMC); and proplatelet-bearing
megakaryocyte (arrow, P-MK). Bar, 10 μm. The bar chart in the right panel shows the frequency of the cells with these morphologies in cultures from the indicated
purified cells. The data are means ± standard error of mean (SEM) (200 cells counted in 8-9 photographs for each culture, from 4 different experiments counted
by 2 independent investigators). (B) Representative contour plots of the indicated cells after 48 h in culture. The numbers in the plots represent the frequency of
the cells in the boxes. Data are means ± SEM, n=4. Fluorescence scales in the plots in panels (A) and (B) are logarithmic. (C) Left, representative histograms showing
the DAPI staining in nuclei of electronically gated CD41++CD42c+ from R2 and R4 cultured cells; right, quantification of cells with 2N-16N in CD41++CD42c+
megakaryo cytes in 48 h STLC from R2 (white), R3 (hatched) and R4 (black) cells. The means ± SEM are shown (n=5). Group comparisons were performed with the
two-tailed Student t-test. (D) Photomicrographs showing CD41 (red) and CD42c (green) staining in cells grown on culture slides (upper panels): bars represent 25
μm (R1, R2 and R4) and 10 μm (R3). White squares indicate the areas amplified in the bottom panels. (E) Expression of PF4 and MPO transcripts in cDNA samples
from E11.5 FL cell populations after STLC. The values for each transcript were calculated relative to the HPRT gene using the 2-DCt method as in Figure 4E. The bars
represent the means ± SEM. R1, n=5; R2, n=4; R3, n=9; R4, n=6. (F) The horizontal bar chart displays the mean fluorescence intensity (MFI) values obtained by
cytometry for the CD45 and CD42c fluorescent labeling of cells after 48 h in cultures from the different subpopulations isolated from the E11.5 FL. The data are
means ± SEM, n=4. Group comparisons were performed with the two-tailed Student t-test. *P<0.05, **P<0.01 and ***P<0.001.
A B
C
D
E F
CD45+, indicating that adult megakaryocytes maintain
CD45 expression along their differentiation. 
In summary, the iAMK and iEMK present among
R2/CD41+CD45+ and R3/CD41+CD45- cells produced
CD41++CD45-CD42c+ EMK in culture, and in the case of
R2/CD41+CD45+ cells also CD41++CD45+CD42c+ AMK,
with a characteristic P-MK morphology, while
CD41++CD42c+ megakaryocytes growing in BM STLC
remained CD45+. Hence, we conclude that in the FL at
E11.5, CD45 levels are modulated in the differentiation
towards CD41++CD42c+ megakaryocytes.
CD45++CD11b+CD115+ cells can differentiate into 
intermediate megakaryocyte stages
As expected from their megakaryocyte potential in CFU
assays (Figure 4G), CD41-CD45++ cells also differentiated
into CD41++CD45+CD42c+ cells, although at the times of
analysis they did not undergo great morphological
CD45-negative megakaryopoiesis in the mouse embryo
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Figure 6. FL CD11b+CD115+ cells have a low megakaryocyte-lineage potential at E11.5. (A) E11.5 fetal liver (FL) cell suspensions were stained with anti-Ter119-
PerCP-Cy5.5, anti-CD11b-APC, anti-CD45-PE-Cy7, anti-CD41-PE and anti-CD42c-FITC antibodies. A representative contour plot (upper left) of Ter119- cells (electron-
ically excluded) displaying CD11b expression on CD45++ cells is shown. The box inside (R5) shows the CD45+CD11b+ cell population that is analyzed for the expres-
sion of CD41 in the bottom left contour plot, identifying cells expressing or not CD41 (R6 and R7 boxes inside the plot). The purified populations of R5/CD45+CD11b+,
R6/CD45+CD11b+CD41- and R7/CD45+CD11b+CD41+ cells were cultured in short-term liquid cultures (STLC) for 48 h, recovered and stained as in Figure 5B.
Representative contour plots (upper right) of the cells recovered for the STLC performed with R5/CD45+CD11b+ purified cells are shown. The boxes in the plots indi-
cate the cell subsets analyzed in the bottom graph, which displays the frequency of the cells grown in STLC from R5, R6 and R7 cells. The data are the means ±
standard error of mean (SEM) (n=3). (B) Cell suspensions were prepared from bone marrow (BM) from 2-month old C57BL/6 and MaFIA mice, and were stained
with anti-CD45-PE-Cy7, anti-CD41-PE, anti-CD9-APC and CD115-BV605. The C57BL/6 preparations also included an anti-CD42c-FITC. Fluorescence-minus-one
(FMO) isotype controls for the CD115 and the CD42c antibodies were included. Representative contour plots display the CD41/CD42c/CD115 (upper plot and his-
togram) or the EGFP/CD41 (bottom plot) signals corresponding to CD9+++ cells (left plot) from C57BL/6 and MaFIA mice, respectively. The histogram shows the
CD115 signal (filled in gray) displayed by CD9++CD41++CD42c+ BM megakaryocytes from C57BL/6 mice. The corresponding FMO isotype control is overlaid (dotted
line). Boxes inside the bottom plot indicate the EGFP- and EGFP+ CD9+++CD41++ cells that were purified by cell sorting and analyzed by real-time quantitative poly-
merase chain reaction (RT-qPCR) for the expression of NE-F2 and VWF transcripts as in Figure 4E. The results of the RT-qPCR are displayed in the bottom histograms
as means ± SEM (n=3). The upper right graph displays the frequency of the cells in EGFP- and EGFP+ regions (data are the means ± SEM, n=4). (C) The expression
of CD115 in E11.5 FL cell preparations from MaFIA mice embryos stained with anti-CD45-PE-Cy7, anti-CD41-PE and anti-CD115-APC antibodies is shown. The quan-
tification of the CD115+ cells among the R1-R4 cell populations (identified as in Figure 4A, left dot-plot) is shown in the graph as means ± SEM (n=3). A represen-
tative contour plot (right) of CD115 expression on EGFP+ cells on electronically gated R1/CD41-CD45++ cells is shown. The number inside the plot represents the fre-
quency of CD115+ cells in the box. (D) Representative contour plots of the FL cell preparations (n =3) from MaFIA mice embryos at E11.5. Electronically selected
EGFP+ and EGFP- cells (indicated by boxes inside the plots) were analyzed for expression of CD45 and CD41 by staining with anti-CD45-PE-Cy7 and anti-CD41-PE
antibodies. The boxes inside the CD45/CD41 plots indicate the CD45++CD41-, CD45+CD41+ and CD45-CD41++ cells, and the number inside is the percentage of CD45-
CD41++ cells. (E) The contour plots show the analyses of the purified EGFP- and EGFP+ cells after sorting (upper contour plots) and after 48 h in STLC (middle contour
plots) stained as in panel (D). The bottom graphs represent the frequency of the cell populations identified in the boxes depicted in the CD45/CD41 plots for the
EGFP- and EGFP+ cells that were growing in the STLC. Data are the means ± SEM (n=3). All fluorescence scales are logarithmic. Results were compared with the
two-tailed Student t-test. *P<0.05, **P<0.01.
A
B
C
D
E
changes nor did they develop proplatelets, and most
CD45++ cells were myelo/monocyte-committed CD11b+
cells ex vivo (Figure 6A and Online Supplementary Figures S3
and S5D). We reasoned that CD45++ cells could be a het-
erogeneous population, containing cells able to differenti-
ate into megakaryocytes. Indeed, low levels of CD41 were
expressed in CD45++CD11b+ cells (Figure 6A). We postu-
lated that these CD41loCD45++CD11b+ cells may be able to
produce CD41++CD45+CD42c+ megakaryocyte-lineage
cells. In fact, more CD41++ cells were obtained in STLC
from purified CD41loCD45++CD11b+ cells than in those
from CD41-CD45++CD11b+ cells (Figure 6A), and there
was a bias towards PF4 expression in cells from
CD41loCD45++CD11b+ cultures (Online Supplementary
Figure S5D).
To confirm these results we used samples from MaFIA
transgenic mice, which allow tracking of cells expressing
the macrophage-specific promoter for Csf1r/CD115.29
We analyzed BM preparations from adult mice, in which
megakaryocytes were identified as Ter119-
CD45+CD9++CD41++CD42c+ (Figure 6B). BM megakary-
ocytes from C57BL/6 mice expressed CD115 (26% ± 5.4
%; n=4). Accordingly, around 30% ± 3.5 % (n=4) of BM
megakaryocytes from MaFIA mice were CD45+EGFP++
cells expressing NF-E2 and VWF transcripts, although at
higher and lower levels, respectively, than those from
EGFP- megakaryocytes. When E11.5 FL preparations
were analyzed, one fifth of CD41-CD45++ cells actually
expressed CD115 brightly at E11.5, and the
CD45++CD115+ were EGFP+ (Figure 6C). However,
among these EGFP+ cells only around 1% were
CD41++CD45- EMK ex vivo (Figure 6D), and when plated
in STLC these EGFP+ cells mainly produced CD41-
CD45++EGFP+ cells and low numbers of CD41+CD45+
EGFP+ cells (Figure 6E). Surprisingly, after STLC some
EGFP- cells became CD41+CD45+/-EGFP+ and
CD41++CD45-EGFP+ cells. This observation indicates that
the FL EGFP- population contains cells with the potential
to become CD115+ in vitro and to generate CD41++
megakaryocytes, which may be reflecting what happens
in vivo in the adult BM. Overall, our findings support the
notion of a low potential of embryo CD45++ cells to pro-
duce CD41+ megakaryocytes in vivo, at difference from
the adult BM situation. 
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Figure 7. Proposed pathways for megakaryopoiesis in the mouse E11.5 embryo liver and in adult bone marrow. Schematic differentiation pathways proposed from
data obtained in the experiments performed with cell populations identified ex vivo in the E11.5 fetal liver (FL) and adult bone marrow (BM), and with the short-term
liquid culture (STLC) differentiation analysis of purified subpopulations after staining with CD45, CD41 and CD42c antibodies. (A) Purified CD45- embryonic c-
Kit++CD41+CD45-CD42c- immature embryo-type CD45- megakaryocytes (iEMK) differentiate into c-Kit+CD41++CD45-CD42c+ embryo-type megakaryocytes (EMK) (STLC
data in Figure 5B,D), and at 24 h become elongated mobile cells (EMC) and differentiate into proplatelet-bearing megakaryocytes (P-MK) after 48 h (bottom left).
(B) Purified adult-type c-Kit++CD41+CD45+CD42c- embryonic immature adult-type CD45+ megakaryocytes (iAMK) [highlight for the authors] (that are CD11b-CD115-,
see Figure 6C) differentiate in STLC (data in Figure 5B and 5D) towards CD45- embryonic-type megakaryocytes (EMK) (middle left plot) and to CD45+ adult-type
megakaryocytes (AMK) (middle-right plot). (C) Cultures from CD41+/-CD45++CD42c-CD11b+CD115+ embryonic progenitors (data in Figure 6E) give rise to CD11b+
myelo/monocytic cells and to a few CD115+ iAMK (right  plot). The bottom-right data correspond to the results from ex vivo staining of cell suspensions from adult
BM (Figure 6B). The c-Kit data were obtained from staining with anti-c-Kit, anti-CD45 and anti-CD41 as shown in Online Supplementary Figures S5 and S6. Black
solid connecting lines indicate results from STLC; red dotted lines are differentiation in adult BM. 
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The morphological, functional and molecular changes
that take place in the differentiation of megakaryocytes
have been assessed here using bulk in vitro cultures of
megakaryocyte-committed progenitors from the E11.5 FL.
One striking finding was that embryonic
CD41++CD42c+CD61++CD9++ megakaryocytes are nega-
tive, until E13.5, for the leukocyte common CD45 antigen,
a large transmembrane glycoprotein expressed on the sur-
face of all hematopoietic cells and their precursors, except
mature erythrocytes and platelets.33,35,36 CD45 accounts for
up to 10% of lymphocyte cell surface proteins and is
involved in the dephosphorylation of the regulatory tyro-
sine of Src family kinases, negatively modulating cell sig-
naling.33,35,36 The CD45 protein sets the threshold for signal
transduction, and CD45 deficiency produces developmen-
tal defects and extended phosphorylation of the
JAK/STAT cascade.37 The absence of CD45 or diminished
levels of this protein have been associated with a hyper-
adhesive phenotype and impairment of progenitor mobi-
lization from the BM.38,39 It could be that the low expres-
sion of CD45 may favor the observed accumulation of
megakaryocytes in FL at E11.5, together with interactions
through integrin receptors that are expressed highly by
megakaryocytes. 
We used CD41 expression to trace megakaryocytes,
since CD41 is expressed strongly by cells of the
megakaryo cyte lineage, including platelets, in the adult
mouse.40 CD41 was defined as a marker for the early
stages of primitive and definitive hematopoiesis in the
mouse embryo,13 and as a marker of HSC in mice and
zebrafish,41,42 tracing the divergence of definitive
hematopoiesis from endothelial cells in mouse c-Kit+ pro-
genitors.40,43 CD41++CD45- megakaryocytes are found in
the YS and embryo (P-Sp/AGM, FL) from E9.5 and in the
circulating blood, as also reported by others.23
Interestingly, E11.5, PreMegE and MKP also display less
CD45 than those from newborn and adult BM, whereas
CD45 levels appear to be similar in other lineage progeni-
tors, revealing a linkage of the CD45-/dim trait to embryo
erythroid/megakaryocyte-lineage cells. Since CD41++
megakaryocytes remain CD45- until E13.5 in the FL, it is
tempting to speculate that CD45- EMK may correspond to
the primitive wave of megakaryopoiesis generating
CD41+CD42c+ Runx1- diploid platelet-forming cells
described in the YS at E10.5.23 The progression of primi-
tive HSC to definitive HSC is dependent on RUNX1.20 At
E11.5 RUNX1-deficient mice have primitive erythrocytes
but lack hematopoietic cells in FL and identifiable platelets
in blood.44 They also lack definitive HSC and CD45+ cells,
and have very few CD41++CD45- cells.20 It would thus be
conceivable that CD45- Runx1+ megakaryocytes present in
the FL at E11.5 belong to the definitive wave of
megakaryo poiesis. However, RUNX1 is essential for
megakaryocyte maturation in the adult BM.45 Therefore,
the fact that EMK in the E11.5 FL are Runx1+, and that
many of them are tetraploid cells with larger size than
those in the contemporaneous YS, may indicate that the
local environment in the FL provides conditions allowing
maturation of primitive wave CD45- megakaryocytes. It
has been described that megakaryocytes require MPL in
order to reach >8N maturation stages after E14.5.24 At
E11.5, after 2 days in culture, the cell subpopulations iso-
lated from FL produced mostly megakaryocytes with 8N
ploidy, which may represent the in vitro differentiation of
MPL-independent megakaryocytes. Also, at E11.5 FL
R4/CD41++CD45- megakaryocytes express the transcrip-
tion factors NF-E2 and Fli1, in agreement with the findings
on a megakaryocyte transcription factor core for YS
diploid platelet-forming cells at E10.5 and for FL
megakaryocytes at E13.5.24
In the FL, CD41 and CD45 expression define several cell
subsets at E11.5. CD41++CD45- cells are already megakary-
ocyte-committed CD42c+MPL+CD9+CD61++AChE+ cells
that develop rapidly in culture to P-MK, whereas CD41-
CD45++ cells are mostly CD11b+ myelo/monocyte-com-
mitted cells. On the other hand, CD41+CD45+ and
CD41+CD45- cells have a more immature phenotype than
the aforementioned populations. The phenotypic data and
the gene expression profile ex vivo, as well as in vitro studies
of these purified populations, prompt us to propose two
major pathways of megakaryocyte differentiation operat-
ing in the E11.5 FL (Figure 7): (i) from CD41+CD45- iEMK,
CD41 is upregulated and CD42c is expressed, producing
EMK (CD41++CD45-CD42c+) that develop proplatelets
with no evidence of CD45 expression (P-MK); (ii) from
CD41+CD45+ iAMK (that are CD115-) (Figure 6C), cells
enter a CD41+CD45+CD42c+ stage from which
CD41++CD45-CD42c+ EMK arise. Therefore, CD45 dimin-
ishes when the levels of CD41 of these increase and they
acquire CD42c to become EMK. The first pathway is
common before E13.5 but becomes rare after E15.5, and it
is currently unknown whether it is even retained at low
levels in the BM, while the reverse applies to the CD45-
derived pathway, although in this case CD45 is retained in
BM CD41++CD42c+ megakaryocytes. Moreover, our data
reveal the involvement of Csf1r-expressing cells in adult
BM CD45+ megakaryopoiesis, which may represent a
third pathway of megakaryopoiesis (Figure 7C), minor or
absent in the embryo, and opens the issue of the genera-
tion of CD41++ megakaryocytes from CD45++CD115-
expressing cells in the adult. Csf1r/CD115 is considered a
mature monocytic differentiation receptor,46 but besides
the high expression of Csf1r in monocytes, macrophages,
osteoclasts and myeloid dendritic cells, it is also expressed
at low levels on HSC, CMP and CLP, as well as among
several non-hematopoietic embryonic cells.47 More work
is needed to clarify the differential contribution of these
CD45++CD11b+CD115+ cells to adult and embryo
megakaryopoiesis and its relevance.
Embryo-fetal-derived megakaryocytes engraft poorly
into adult mice and produce low number of platelets.48,49 It
is presently unknown whether the different subsets of
megakaryocyte progenitors identified in the embryo may
give rise to functional or immature platelets in vivo, but
they may represent new tools to uncover the mechanisms
underlying the maturation of the membrane demarcation
system assembly machinery that yields platelets, similarly
as the recently described mechanisms by which BM
megakaryocytes sense extracellular matrix rigidity to
release platelets.50 In summary, we present a number of
findings proving that embryo megakaryocytes are
hematopoietic CD45- nucleated cells that are produced
from CD45- and CD45+ progenitor cells, findings that may
be extended to human cord blood samples in order to
probe the existence of a human CD45- megakaryocyte
counterpart. These issues have relevant implications for
understanding aberrant megakaryopoiesis processes and
megakaryocyte-derived tumors, and also represent a tool
CD45-negative megakaryopoiesis in the mouse embryo
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that may provide clues to improve megakaryocyte recon-
stitution by using cord blood-derived progenitors for
transplantation and for designing better conditions to
increase platelet production to treat thrombocytopenic
pathologies.
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